Leah Prentice

11.6k total citations · 1 hit paper
26 papers, 2.2k citations indexed

About

Leah Prentice is a scholar working on Reproductive Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leah Prentice has authored 26 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leah Prentice's work include Ovarian cancer diagnosis and treatment (7 papers), Hypothalamic control of reproductive hormones (4 papers) and Genomics and Rare Diseases (2 papers). Leah Prentice is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Hypothalamic control of reproductive hormones (4 papers) and Genomics and Rare Diseases (2 papers). Leah Prentice collaborates with scholars based in Canada, United States and United Kingdom. Leah Prentice's co-authors include David G. Huntsman, C. Blake Gilks, Steve E. Kalloger, Janine Senz, Sohrab P. Shah, Winnie Yang, Martin Köbel, Jessica N. McAlpine, Steven McKinney and Jennifer L. Santos and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Leah Prentice

26 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

2008 618 citations Martin Köbel, Steve E. Kalloger et al. PLoS Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leah Prentice Canada	18	1.0k	909	552	540	456	26	2.2k
Jennifer L. Santos Canada	13	1.3k 1.2×	809 0.9×	416 0.8×	558 1.0×	527 1.2×	21	2.0k
Narciso Olvera United States	27	942 0.9×	1.1k 1.3×	634 1.1×	421 0.8×	600 1.3×	44	2.4k
Nobuyuki Susumu Japan	32	1.1k 1.1×	1.1k 1.2×	656 1.2×	1.3k 2.4×	743 1.6×	140	3.1k
Rosalind Glasspool United Kingdom	25	753 0.7×	842 0.9×	722 1.3×	375 0.7×	193 0.4×	86	1.9k
Christian Kurzeder Germany	25	1.0k 1.0×	363 0.4×	709 1.3×	494 0.9×	290 0.6×	88	2.0k
Patricia A. Shaw Canada	29	1.4k 1.4×	976 1.1×	1.1k 1.9×	348 0.6×	623 1.4×	57	3.0k
Katja Gwin United States	18	511 0.5×	1.3k 1.4×	659 1.2×	315 0.6×	1.3k 2.7×	48	2.6k
S A Cannistra United States	11	1.1k 1.0×	816 0.9×	644 1.2×	302 0.6×	402 0.9×	11	2.4k
Michael S. Anglesio Canada	32	1.8k 1.8×	1.5k 1.6×	652 1.2×	1.3k 2.3×	737 1.6×	71	3.6k
Ruth Perets Israel	18	613 0.6×	914 1.0×	1.3k 2.3×	394 0.7×	493 1.1×	61	2.7k

Countries citing papers authored by Leah Prentice

Since Specialization

Citations

This map shows the geographic impact of Leah Prentice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah Prentice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah Prentice more than expected).

Fields of papers citing papers by Leah Prentice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah Prentice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah Prentice. The network helps show where Leah Prentice may publish in the future.

Co-authorship network of co-authors of Leah Prentice

This figure shows the co-authorship network connecting the top 25 collaborators of Leah Prentice. A scholar is included among the top collaborators of Leah Prentice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah Prentice. Leah Prentice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobsen, Julius O.B., Christèle du Souich, Kent Shefchek, et al.. (2022). The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice. Genetics in Medicine. 24(7). 1512–1522. 3 indexed citations

Tessier‐Cloutier, Basile, Jennifer Pors, Emily F. Thompson, et al.. (2020). Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome. Modern Pathology. 34(2). 508–518. 46 indexed citations

Tessier‐Cloutier, Basile, Kim E. Kortekaas, Emily F. Thompson, et al.. (2020). Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status. Modern Pathology. 33(8). 1595–1605. 118 indexed citations

Prentice, Leah, Ruth R. Miller, Jeff Knaggs, et al.. (2018). Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice. PLoS ONE. 13(4). e0196434–e0196434. 41 indexed citations

Anglesio, Michael S., Ali Bashashati, Yi Kan Wang, et al.. (2015). Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. The Journal of Pathology. 236(2). 201–209. 116 indexed citations

Burleigh, Angela, Steven McKinney, Jazmine Brimhall, et al.. (2015). A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation. Breast Cancer Research. 17(1). 4–4. 14 indexed citations

Anglesio, Michael S., Kimberly C. Wiegand, Nataliya Melnyk, et al.. (2013). Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research. PLoS ONE. 8(10). 31 indexed citations

McConechy, Melissa K., Jiarui Ding, Janine Senz, et al.. (2013). Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Modern Pathology. 27(1). 128–134. 186 indexed citations

Anglesio, Michael S., Kimberly C. Wiegand, Nataliya Melnyk, et al.. (2013). Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research. PLoS ONE. 8(9). e72162–e72162. 197 indexed citations

10.

McAlpine, Jessica N., Martin Köbel, Brad H. Nelson, et al.. (2012). BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Modern Pathology. 25(5). 740–750. 129 indexed citations

11.

Prentice, Leah, Xavier d’Anglemont de Tassigny, Steven McKinney, et al.. (2011). The testosterone-dependent and independent transcriptional networks in the hypothalamus of Gpr54 and Kiss1 knockout male mice are not fully equivalent. BMC Genomics. 12(1). 209–209. 12 indexed citations

12.

McConechy, Melissa K., Michael S. Anglesio, Steve E. Kalloger, et al.. (2011). Subtype‐specific mutation of PPP2R1A in endometrial and ovarian carcinomas. The Journal of Pathology. 223(5). 567–573. 86 indexed citations

13.

Yap, Damian, David C. Walker, Leah Prentice, et al.. (2011). Mll5 Is Required for Normal Spermatogenesis. PLoS ONE. 6(11). e27127–e27127. 37 indexed citations

14.

Köbel, Martin, Steve E. Kalloger, Niki Boyd, et al.. (2008). Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies. PLoS Medicine. 5(12). e232–e232. 618 indexed citations breakdown →

15.

Prentice, Leah, Christian Klausen, Steve E. Kalloger, et al.. (2007). Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. BMC Medicine. 5(1). 33–33. 51 indexed citations

16.

Prentice, Leah, Melinda A. Miller, Dmitry Turbin, Samuel Aparício, & David G. Huntsman. (2006). expression of GPR54 and KiSS1 in human breast cancer. Cancer Research. 66. 1013–1014. 1 indexed citations

17.

Prentice, Leah, Ashleen Shadeo, Valia S. Lestou, et al.. (2005). NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene. 24(49). 7281–7289. 52 indexed citations

18.

Beech, R, et al.. (1989). Genetic services in the context of DNA probes: what do they cost?. Journal of Medical Genetics. 26(4). 237–244. 6 indexed citations

19.

Hillman, David R., Leah Prentice, & Kevin E. Finucane. (1986). The pattern of breathing in acute severe asthma.. PubMed. 133(4). 587–92. 24 indexed citations

20.

Hillman, David R., Leah Prentice, & Kevin E. Finucane. (1985). The Pattern of Breathing in Acute Severe Asthma. CHEST Journal. 87(5). 217S–218S. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact